• Emergency Use Approval by the Ministry of Food and Drug Safety of South Korea (MFDS)
• Result turnaround time of 35 minutes*** post extraction with high clinical performance
*Registered trademark in South Korea.
**Not for sale in the U.S.
***Run time may vary by testing lab parameter.
The Ezplex SARS-CoV-2 FAST G Kit is a real-time PCR in vitro diagnostic test intended for the qualitative detection of nucleic acid SARS-CoV-2 (RdRp, N genes) in individuals suspected of COVID-19 (nasopharyngeal/oropharyngeal and sputum specimens).
The test can be quickly completed within 35 minutes post extraction through Real-time PCR assays with extracted RNA, and the results can be conveniently checked using Genetree Viewer assay software.
How is the Ezplex SARS-CoV-2 FAST G Kit different from the Ezplex SARS-CoV-2 G Kit?
The Ezplex SARS-CoV-2 FAST G Kit is an alternative version of the Ezplex SARS-CoV-2 G Kit, with reduced testing completion time of approximately 35 minutes post extraction. We recommend using the CFX96 Dx Touch Real-Time PCR instrument (Bio-Rad) or ABI QuantStudio 6 Flex Real-Time PCR Instrument (ThermoFisher Scientific) for the Ezplex SARS-CoV-2 FAST G Kit.
Features and Benefits
35 minutes post extraction.
Detection and identification of target genes (RdRP, N) specific for COVID-19.
99-100% clinical sensitivity and 100% clinical specificity.
Reproducibility of less than 5% CV.
Detection of SARS-CoV-2 (RdRp and N genes) with high sensitivity, regardless of virus mutations.
Test results can be easily analyzed with dedicated user-friendly Genetree Viewer assay software.